BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Komatsuzaki K, Terashita K, Kinane TB, Nishimoto I. Somatostatin type V receptor activates c-Jun N-terminal kinases via Galpha(12) family G proteins. Biochem Biophys Res Commun. 2001;289:1211-1217. [PMID: 11741322 DOI: 10.1006/bbrc.2001.6085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang CH, Tang CW, Liu CL, Tang LP. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World J Gastroenterol 2003; 9(9): 1904-1908 [PMID: 12970873 DOI: 10.3748/wjg.v9.i9.1904] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
2 Siehler S. Regulation of RhoGEF proteins by G12/13-coupled receptors. Br J Pharmacol 2009;158:41-9. [PMID: 19226283 DOI: 10.1111/j.1476-5381.2009.00121.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 11.5] [Reference Citation Analysis]
3 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 35.0] [Reference Citation Analysis]
4 Siehler S. G12/13-dependent signaling of G-protein-coupled receptors: disease context and impact on drug discovery. Expert Opin Drug Discov 2007;2:1591-604. [PMID: 23488903 DOI: 10.1517/17460441.2.12.1591] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sprecher U, Mohr P, Martin RE, Maerki HP, Sanchez RA, Binggeli A, Künnecke B, Christ AD. Novel, non-peptidic somatostatin receptor subtype 5 antagonists improve glucose tolerance in rodents. Regul Pept 2010;159:19-27. [PMID: 19761802 DOI: 10.1016/j.regpep.2009.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
6 Zou A, Huo M, Zhang Y, Zhou J, Yin X, Yao C, Zhu Q, Zhang M, Ren J, Zhang Q. Octreotide-Modified N-Octyl-O, N-Carboxymethyl Chitosan Micelles as Potential Carriers for Targeted Antitumor Drug Delivery. Journal of Pharmaceutical Sciences 2012;101:627-40. [DOI: 10.1002/jps.22798] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
7 Pecere T, Ponterio E, Di Iorio E, Carli M, Fassan M, Santoro L, Bissaro M, Bernabè G, Moro S, Castagliuolo I, Palù G. On the mechanism of tumor cell entry of aloe-emodin, a natural compound endowed with anticancer activity. Int J Cancer 2021;149:1129-36. [PMID: 33990938 DOI: 10.1002/ijc.33686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cakir M, Dworakowska D, Grossman A. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. J Cell Mol Med 2010;14:2570-84. [PMID: 20629989 DOI: 10.1111/j.1582-4934.2010.01125.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
9 Lahlou H, Guillermet J, Hortala M, Vernejoul F, Pyronnet S, Bousquet C, Susini C. Molecular signaling of somatostatin receptors. Ann N Y Acad Sci. 2004;1014:121-131. [PMID: 15153426 DOI: 10.1196/annals.1294.012] [Cited by in Crossref: 109] [Cited by in F6Publishing: 93] [Article Influence: 6.4] [Reference Citation Analysis]
10 Wu Z, Tandon R, Ziembicki J, Nagano J, Hujer KM, Miller RT, Huang C. Role of ceramide in Ca2+-sensing receptor-induced apoptosis. J Lipid Res 2005;46:1396-404. [PMID: 15805541 DOI: 10.1194/jlr.M500071-JLR200] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Hua Y, Ma H, Samson WK, Ren J. Neuronostatin inhibits cardiac contractile function via a protein kinase A- and JNK-dependent mechanism in murine hearts. Am J Physiol Regul Integr Comp Physiol 2009;297:R682-9. [PMID: 19553502 DOI: 10.1152/ajpregu.00196.2009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
12 Schonbrunn A. Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol. 2008;286:35-39. [PMID: 18006219 DOI: 10.1016/j.mce.2007.09.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
13 Kang KW, Choi SY, Cho MK, Lee CH, Kim SG. Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation. J Biol Chem 2003;278:17368-78. [PMID: 12606553 DOI: 10.1074/jbc.M300471200] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]